(Q37809764)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Emerging topics and new perspectives on HLA-G (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author

Massimiliano Castellazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Fabio Morandi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Etienne Sokal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Enrico Fainardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marina Stignani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gwenaëlle Sana

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rafael Gonzalez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Vito Pistoia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Olavio Roberto Baricordi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Josè Peña

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

1 reference

16 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

433-451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-010-0584-3

16 January 2020

exact match

0 references

cites work

HLA-G: from biology to clinical benefits

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

A class I antigen, HLA-G, expressed in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Biology and functions of human leukocyte antigen-G in health and sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G expression is a fundamental prerequisite to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G: Are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G: a shield against inflammatory aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Treatment of intracerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mechanisms of brain injury after intracerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Theoretical and experimental optimization of laser speckle contrast imaging for high specificity to brain microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G in the skin--friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G is associated with pemphigus vulgaris in Jewish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Expression of human leukocyte antigen-G in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Allele-specific targeting of microRNAs to HLA-G and risk of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G and IL-10 expression in human cancer--different stories with the same message

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Immunoregulatory function of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cells: a new strategy for immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Nef interference with HIV-1-specific CTL antiviral activity is epitope specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Modulation of HLA-G expression in human neural cells after neurotropic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cells: clinical applications and biological characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G expression is up-regulated by progesterone in mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Immune properties of human umbilical cord Wharton's jelly-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

HLA-G Expression in Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0584-3

Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients

21 January 2018

1 reference

12 December 2020

The role of human leukocyte antigen E and G in HIV infection

1 reference

12 December 2020

HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

1 reference

12 December 2020

HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus

1 reference

12 December 2020

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

1 reference

12 December 2020

New advances in coeliac disease: serum and intestinal expression of HLA-G

1 reference

12 December 2020

A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells

1 reference

12 December 2020

Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells.

1 reference

12 December 2020

Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma

1 reference

12 December 2020

Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule

1 reference

12 December 2020

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

12 December 2020

Expression of HLA-G in the skin of patients with pemphigus vulgaris

1 reference

12 December 2020

Inflammation after intracerebral hemorrhage

1 reference

12 December 2020

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

1 reference

12 December 2020

Plasma soluble human leukocyte antigen G levels in asthmatic children

1 reference

12 December 2020

Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population

1 reference

12 December 2020

Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis

1 reference

12 December 2020

Expression of HLA-G in human cornea, an immune-privileged tissue

1 reference

12 December 2020

Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection

1 reference

12 December 2020

Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens

1 reference

12 December 2020

The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease

1 reference

12 December 2020

Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege

1 reference

12 December 2020

Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes?

1 reference

12 December 2020

Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells

1 reference

12 December 2020

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G

1 reference

12 December 2020

Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice

1 reference

12 December 2020

Viral mechanisms of immune evasion

1 reference

12 December 2020

Soluble HLA-G in Rheumatoid Arthritis

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis

1 reference

12 December 2020

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

12 December 2020

Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers

1 reference

12 December 2020

Cytomegalovirus immune evasion.

1 reference

12 December 2020

Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool?

1 reference

12 December 2020

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

1 reference

12 December 2020

HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein

1 reference

12 December 2020

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

1 reference

12 December 2020

10.1007/S00018-010-0584-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21080027%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference